Glaukos Corporation · NYSE:GKOS
Glaukos — Q1 2022 Earnings Presentation
4 slides from Glaukos's earnings presentation, May 4, 2022
Slide 1: We'll Go First
WE'LL GO FIRST Innovation is at the core of everything we do. At Glaukos, we push the limits of science and technology to solve unmet needs in chronic eye diseases. GLAUKOS TRANSFORMING VISION
Slide 2: U.S. Glaucoma
U.S. Glaucoma Our first quarter U.S. Glaucoma net revenues were approximately $33.9 million, down 15% year-over-year reflecting a combination of pandemic-related dynamics, and U.S. combination cataract glaucoma dynamics associated in particular with the 2022 CMS final Physician Fee reimbursement
Slide 3: Glaukos Pipeline Summary
‘Gaukos Pipeline Summary G) oan Cavey nn nn ps gery =e Ze Garena arene oe aes g Sentate a oe tng 8 eS Tecan SS Pa aot ana a 3 sonia mo EO aw Delica eaaay icon, “ppuisaleehateetera arm io enn Gace ei Loree ex Oy Oaene Pose Bact emsing —— aon Pesos Pose 2 cic ensing io mason tooth Kenta rosea satis Ba
Slide 4: Additional Information
iN Additional Information
Glaukos — Q1 2022 Earnings Presentation on 6ix